Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 5, 2007, Pages 213-218

  Mori, Daisuke ^a   Ishii, Hideto ^a   Kojima, Chiari ^a,b   Nitta, Noriko ^a   Nakajima, Katsuyuki ^c   Yoshida, Masayuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c Japan Immunoresearch Laboratories   (Japan)

Author keywords

Atherosclerosis; Leukocyte endothelial; Phosphodiesterase type III (PDE3); THP 1 cells

Indexed keywords

ANTITHROMBOCYTIC AGENT; CILOSTAZOL; CYCLIC AMP; INTEGRIN; TETRAZOLE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL ADHESION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; FETUS BLOOD; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; LEUKOCYTE ROLLING; METABOLISM; MONOCYTE; UPREGULATION; VASCULAR ENDOTHELIUM;

CELL ADHESION; CELLS, CULTURED; CYCLIC AMP; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; IMMUNOASSAY; INTEGRINS; LEUKOCYTE ROLLING; MONOCYTES; PLATELET AGGREGATION INHIBITORS; TETRAZOLES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 38449096302     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E492     Document Type: Article

References (25)

1. Lee DK, Nathan Grantham R, Trachte AL, Mannion JD, and Wilson CL: Activation of the canonical Wnt/betacatenin pathway enhances monocyte adhesion to endothelial cells. Biochem Biophys Res Commun, 2006; 347:109-116
2. Chen JW, Chen YH, Lin FY, Chen YL, and Lin SJ: Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler Thromb Vasc Biol, 2003; 23:1559-1566
3. Schleser S, Ringseis R, and Eder K: Conjugated linoleic acids have no effect on TNFalpha-induced adhesion molecule expression, U937 monocyte adhesion, and chemokine release in human aortic endothelial cells. Atherosdcrosis, 2006; 186:337-344
4. Inoue T, Uchida T, Sakuma M, Imoto Y, Ozeki Y, Ozaki Y, Hikichi Y, and Node K: Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation. J Am Coll Cardiol, 2004; 44:1408-1414
5. Park SY, Lee JH, Kim CD, Lee WS, Park WS, Han J, Kwak YG, Kim KY, and Hong KW. Cilostazol Suppresses Superoxide Production and Expression of Adhesion Molecules in Human Endothelial Cells via Mediation of cAMP-dependent Protein Kinase-mediated Maxi-K Channel Activation. J Pharmacol Exp Ther, 2006; 317:1238-1245
6. Yang Y, Luo J, Kazumura K, Takeuchi K, Inui N, Hayashi H, Ohashi K, and Watanabe H: Cilostazol suppresses adhesion of human neutrophils to HUVECs stimulated by FMLP and its mechanisms. Life Sci, 2006; 79:629-636
7. Heijnen HE Waaijenhorg S, Crapo JD, Bowler RP, Akkerman JW, and Slot JW. Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production. J Histochem Cytochem, 2004; 52:1277-1285
8. Hashimoto A, Miyakoda G, Hirose Y, and Mori T: Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis, 2006; 189:350-357
9. Gerszten RE, Garcia-Zepeda EA, Lim YC, Yoshida M, Ding HA, Gimbrone MA Jr., Luster AD, Luscinskas FW, and Rosenzweig A: MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature, 1999; 398:718-723
10. Gerszten RE, Luscinskas FW, Ding HT, Dichek DA, Sroolman LM, Gimbrone MA Jr., and Rosenzweig A: Adhesion of memory lymphocytes to vascular cell adhesion molecule-1-transduced human vascular endothelial cells under simulated physiological flow conditions in vitro. Circ Res, 1996; 79:1205-1215
11. Luscinskas FW, Kansas GS, Ding H, Pizcueta P, Schleiffenbaum BE, Tedder TF, and Gimbrone MA Jr.: Monoyt rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J Cell Biol, 1994; 125:1417-1427
12. Bevilacqua MP, Nelson RM, Mannori G, and Cecconi O: Endothelial-leukocyte adhesion molecules in human disease. Annu Rev Med, 1994; 45:361-378
13. Yoshida M, Szente BE, Kiely JM, Rosenzweig A, and Gimbrone MA Jr.: Phosphorylation of the cytoplasmic domain of E-selectin is regulated during leukocyte-endothelial adhesion. J Immunol, 1998; 161:933-941
14. Dousa TP: Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int, 1999; 55:29-62
15. Movsesian MA and Alharethi R: Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy. Expert Opin Investig Drugs, 2002; 11:1529-1536
16. Netherton SJ and Maurice DH: Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol Pharmacol, 2005; 67:263-272
17. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kurabayashi M, and Kasayama S: Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence. Atherosclerosis, 2001; 158:121-128
18. Park SY, Lee JH, Kim YK, Kim CD, Rhim BY, Lee WS, and Hong KW. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther, 2005; 312:1241-1248
19. Iyengar R. Gating by cyclic AMP: expanded role for an old signaling pathway. Science, 1996; 271:461-463
20. Bryn T, Mahic M, Enserink JM, Schwede F, Aandahl EM, and Tasken K: The cyclic AMP-Epacl-Rapl pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages. J Immunol, 2006; 176:7361-7370
21. 2+ mobilization and its regulation in platelet activation]. Rinsho Ketsueki, 1991; 32:467-474
22. 2+ mobilization and aggregation. Anesthesiology, 1998; 89:401-410
23. 2+ channel blockers. Am J Physiol, 1999; 276:E856-E862
24. Gao L, Wang F, Wang B, Gong B, Zhang J, Zhang X, and Zhao J: Cilostazol protects diabetic rats from vascular inflammation via nuclear factor-kappa B-dependent down-regulation of vascular cell adhesion molecule-1 expression. J Pharmacol Exp Ther, 2006; 318:53-58
25. Ohba R, Otaka M, Odashima M, Jin M, Komatsu K, Konishi N, Wada I, Horikawa Y, Matsuhashi T, Oyake J, Hatakeyama N, and Watanabe S: Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats. J Gastroenterol, 2006; 41:34-40